HSPA4 and hepatocellular carcinoma: HSPA4 expression showed a good ability to distinguish tumor from normal tissue, and to predict 1-, 3-, and 5-year survival rates, indicating that it can be used as a potential valuable diagnostic and prognostic biomarker for HCC.